Gustaaf W van Imhoff

Rituximab improves the treatment results of DHAP-VIM-DHAP and ASCT in relapsed/progressive aggressive CD20+ NHL: a prospective randomized HOVON trial.

E. Vellenga, W. van Putten, J. Zijlstra, 2006, Blood.

Double-hit B-cell lymphomas.

Philip M Kluin, Ed Schuuring, Reiner Siebert, 2011, Blood.